CareDx EBITDA Margin 2013-2025 | CDNA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CareDx (CDNA) over the last 10 years. The current EBITDA margin for CareDx as of March 31, 2025 is .
| CareDx EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.35B | $0.07B | 19.88% |
| 2024-12-31 | $0.33B | $0.06B | 18.26% |
| 2024-09-30 | $0.31B | $-0.14B | -44.73% |
| 2024-06-30 | $0.30B | $-0.16B | -53.87% |
| 2024-03-31 | $0.28B | $-0.18B | -66.91% |
| 2023-12-31 | $0.28B | $-0.19B | -67.14% |
| 2023-09-30 | $0.30B | $-0.08B | -28.38% |
| 2023-06-30 | $0.31B | $-0.07B | -23.38% |
| 2023-03-31 | $0.32B | $-0.07B | -20.69% |
| 2022-12-31 | $0.32B | $-0.06B | -19.00% |
| 2022-09-30 | $0.32B | $-0.06B | -18.24% |
| 2022-06-30 | $0.32B | $-0.05B | -15.87% |
| 2022-03-31 | $0.31B | $-0.03B | -10.71% |
| 2021-12-31 | $0.30B | $-0.02B | -5.41% |
| 2021-09-30 | $0.28B | $0.00B | -1.45% |
| 2021-06-30 | $0.25B | $0.00B | 0.40% |
| 2021-03-31 | $0.22B | $-0.01B | -3.17% |
| 2020-12-31 | $0.19B | $-0.01B | -6.77% |
| 2020-09-30 | $0.17B | $-0.02B | -9.47% |
| 2020-06-30 | $0.15B | $-0.02B | -13.33% |
| 2020-03-31 | $0.14B | $-0.02B | -12.23% |
| 2019-12-31 | $0.13B | $-0.02B | -13.39% |
| 2019-09-30 | $0.12B | $-0.02B | -13.04% |
| 2019-06-30 | $0.10B | $-0.01B | -12.75% |
| 2019-03-31 | $0.09B | $-0.01B | -12.36% |
| 2018-12-31 | $0.08B | $-0.01B | -11.69% |
| 2018-09-30 | $0.07B | $-0.01B | -16.67% |
| 2018-06-30 | $0.06B | $-0.01B | -22.81% |
| 2018-03-31 | $0.05B | $-0.01B | -15.69% |
| 2017-12-31 | $0.05B | $-0.01B | -26.53% |
| 2017-09-30 | $0.05B | $-0.03B | -57.45% |
| 2017-06-30 | $0.05B | $-0.03B | -53.19% |
| 2017-03-31 | $0.05B | $-0.03B | -67.39% |
| 2016-12-31 | $0.04B | $-0.03B | -73.17% |
| 2016-09-30 | $0.04B | $-0.02B | -45.95% |
| 2016-06-30 | $0.03B | $-0.02B | -56.25% |
| 2016-03-31 | $0.03B | $-0.02B | -57.14% |
| 2015-12-31 | $0.03B | $-0.01B | -39.29% |
| 2015-09-30 | $0.03B | $-0.01B | -24.14% |
| 2015-06-30 | $0.03B | $0.00B | -6.90% |
| 2015-03-31 | $0.03B | $0.00B | 3.45% |
| 2014-12-31 | $0.03B | $0.00B | 7.14% |
| 2014-09-30 | $0.03B | $0.00B | 11.54% |
| 2014-06-30 | $0.03B | $0.00B | 4.00% |
| 2014-03-31 | $0.02B | $0.00B | 4.35% |
| 2013-12-31 | $0.02B | $0.00B | 4.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.715B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.222B | 26.93 |
| CVS Health (CVS) | United States | $74.320B | 9.24 |
| Elevance Health (ELV) | United States | $63.147B | 8.49 |
| Cencora (COR) | United States | $56.296B | 19.58 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $22.406B | 17.68 |
| Natera (NTRA) | United States | $19.262B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| ICON (ICLR) | Ireland | $15.748B | 15.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.835B | 0.00 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.801B | 33.88 |
| Solventum (SOLV) | United States | $12.791B | 13.54 |
| Revvity (RVTY) | United States | $12.019B | 20.68 |
| Viatris (VTRS) | United States | $10.974B | 3.77 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.287B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.698B | 17.05 |
| HealthEquity (HQY) | United States | $8.162B | 35.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.632B | 33.32 |
| Sotera Health (SHC) | United States | $3.437B | 19.53 |
| Surgery Partners (SGRY) | United States | $2.693B | 35.02 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Concentras Parent (CON) | United States | $2.517B | 14.55 |
| GeneDx Holdings (WGS) | United States | $2.324B | 89.50 |
| Alignment Healthcare (ALHC) | United States | $2.303B | 0.00 |
| Progyny (PGNY) | United States | $1.972B | 43.40 |
| GoodRx Holdings (GDRX) | United States | $1.775B | 35.50 |
| Premier (PINC) | United States | $1.747B | 13.26 |
| PACS (PACS) | United States | $1.742B | 0.00 |
| Ardent Health (ARDT) | United States | $1.543B | 6.58 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.067B | 8.12 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.857B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.750B | 7.03 |
| Embecta (EMBC) | United States | $0.665B | 4.48 |
| Nutex Health (NUTX) | United States | $0.532B | 8.05 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| Omada Health (OMDA) | $0.486B | 0.00 | |
| LifeMD (LFMD) | United States | $0.485B | 0.00 |
| So-Young (SY) | China | $0.480B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.349B | 28.71 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.187B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.083B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |